Sale!

Replica: Osimertinib EGFRm NSCLC Targeted Therapy

Original price was: $698.00.Current price is: $539.00.

Third-generation irreversible EGFR-TKI, treats NSCLC with EGFR Ex19Del or EGFR L858R mutations, CNS metastasis activity, for EGFRm NSCLC patients,

SKU: SKU67EGOQZIQ Category:
Guaranteed Safe Checkout

Third-generation irreversible EGFR-TKI, treats NSCLC with EGFR Ex19Del or EGFR L858R mutations, CNS metastasis activity, for EGFRm NSCLC patients,

Reviews

There are no reviews yet.

Be the first to review “Replica: Osimertinib EGFRm NSCLC Targeted Therapy”

Your email address will not be published. Required fields are marked *

Scroll to Top